Sunesis Pharmaceuticals
Region | Nordamerika |
ISIN | US8673288747 |
Sektor | Biotechnologie |
Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
Titel | Autor | Datum |
---|---|---|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 1 Jahren |
Titel | Datum |
---|---|
MISC rises to highest since Nov 2020 as KLCI declines | vor ungefähr 4 Monaten |
Lloyd's Register, Samsung Heavy Industries and MISC ink MOU for zero-emission VLCCs | vor ungefähr 4 Monaten |
Moody's assigns provisional Baa2 rating to MISC MTN programme | vor ungefähr 4 Monaten |
MISC poised to continue uptrend, says RHB Retail Research | vor ungefähr 5 Monaten |
MISC unit to undertake Global Medium Term Note programme of up to US$3b | vor ungefähr 5 Monaten |
Diese Aktien könnten Dich auch interessieren | |
---|---|
Suedzucker (1 Artikel) | |
Stockholm IT Ventures AB (1 Artikel) | |
Tahoe Resources (1 Artikel) | |
Telit Communications (3 Artikel) | |
Alle anzeigen |